| Website | phasebio.com |
| Category | BioTech |
| Phone | 610-981-6500 |
| Employees | |
| Founded | 2002 |
| TOTAL | $31.6M |
| VENTURE FUNDING TOTAL | $31.6M |
| Series B, 10/07 Fletcher Spaght Ventures Johnson & Johnson Development Hatteras Venture Partners | $6.6M |
| Series B, 1/10 New Enterprise Associates OSI Pharmaceuticals Hatteras Venture Partners Johnson & Johnson Development Fletcher Spaght Ventures | $25M |
PhaseBio Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the generation of biopharmaceuticals. It offers elastin-like peptides (ELP) technology for drug delivery; and deltaPhase, purification technology. Its technology is based on biopolymers of elastin-like repeating subunits to which drugs are attached or peptides and proteins genetically fused enhancing the pharmacology and delivery of therapeutics. PhaseBio Pharmaceuticals, Inc. was formerly known as Phase Bioscience, Inc. and it changed its name in November 2008. The company was founded in 2002 and is based in Morrisville, North Carolina.
